Dr. Brian Rini discussed the benefits of treating patients with relapsed or refractory renal cell carcinoma with the vascular endothelial growth factor tyrosine kinase inhibitor. The tolerability ...

Phase 4 COMPARE trial data show Nuvaxovid was associated with lower reactogenicity and fewer daily activity disruptions than mNEXSPIKE.

Phase 1/1b study of SY-5609, a selective and potent CDK7 inhibitor, in advanced solid tumors and in 2L/3L pancreatic ductal adenocarcinoma (PDAC) in combination with gemcitabine +/- nab-paclitaxel.

Please provide your email address to receive an email when new articles are posted on . Applying moisturizer before the fixed-combination vs. after did not yield significant differences in efficacy.

Late Recurrence of Childhood T-Cell Acute Lymphoblastic Leukemia Frequently Represents a Second Leukemia Rather Than a Relapse: First Evidence for Genetic Predisposition In all, 1,014 newly diagnosed ...

In a recent study published in JAMA Network Open, a team of researchers investigated the tolerability and safety of a microbiome therapy called SER-109 to treat recurrent infections of Clostridioides ...

Erectile dysfunction (ED) is a symptom of many underlying conditions, and some of the known risk factors for this disease include diabetes mellitus, hypogonadism in association with a number of ...

A phase 2a trial of Sensorion’s vertigo seliforant has met its primary tolerability endpoint. The trial found the histamine type 4 receptor antagonist had no effect on vigilance and cognitive ...